India Diabetes Care Devices Market Analysis and Forecasts to 2015

GlobalData, April 2009, Pages: 79

India Diabetes Care Devices Market Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the India diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in India.

Scope

- The report provides Diabetes care devices market information broken down into detailed categories and segments in India.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in India.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Executive Summary 10
4 Definitions of Markets Covered in the Report 11
4.1 Diabetic Care Devices 11
4.2 Glucose Monitoring Devices 11
4.2.1 Blood Glucose Meters 11
4.2.2 Blood Glucose Strips 11
4.3 Insulin Delivery 11
4.3.1 InsulinPens 11
4.3.2 Insulin Syringes 12
4.3.3 Insulin Pumps 12
4.3.4 Traditional Insulin Pump Accessories 12
5 Healthcare Sector Review 13
5.1 Healthcare Expenditure 13
5.2 Healthcare Infrastructure 15
5.2.1 Healthcare Personnel Data 16
5.2.2 Healthcare Facilities Data 17
5.3 Healthcare Policy 18
6 Regulation System 19
6.1 Medical Equipment Approval 19
6.2 Central Drugs Authority of India (CDAI) 20
6.3 Medical Device Regulatory Authority of India (MDRAI) 20
6.4 Classification of medical devices 20
6.4.1 Registration Period 21
7 Pricing and Reimbursement 22
7.1 Pricing and Reimbursement 22
8 Distribution Structure 23
8.1 Distribution Structure 23
9 Diabetes Care Devices In India 24
9.1 Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2015 24
9.2 Diabetes Care Devices, India, Category Volume (Units), 2000-2015 26
9.3 Diabetes Care Devices, India, Cross Category Analysis, 2000-2015 28
9.4 Diabetes Care Devices, Market Dynamics 30
9.4.1 Market Drivers 30
9.4.2 Market Restraints 30
9.5 Indian Diabetes Epidemiology 31
9.6 Diabetes Care Devices, India Company Share (2006-2007) 32
9.7 Future Outlook 33
10 Glucose Monitoring In India 34
10.1 Glucose Monitoring Overall Revenue (2000-2015) 34
10.2 Glucose Monitoring Overall Volume (2000-2015) 36
10.3 Glucose Monitoring, India, Cross Segment Analysis, 2000-2015 38
10.4 Glucose Monitoring Average Price (2000-2015) 39
10.4.1 Glucose Monitoring Market Dynamics 40
10.5 Glucose Monitoring Distribution Share (2007-2008) 40
10.6 Glucose Monitoring, India, Company Share (2006-2007) 41
11 Insulin Delivery In India 42
11.1 Insulin Delivery Overall Revenue (2000-2015) 42
11.1.1 Insulin Pens Revenue (2000-2015) 45
11.2 Insulin Delivery Overall Volume (2000-2015) 47
11.3 Insulin Delivery, India, Cross Segment Analysis, 2000-2015 48
11.4 Insulin Delivery Average Price (2000-2015) 50
11.4.1 Insulin Delivery Market Dynamics 51
11.5 Insulin Delivery Distribution Share (2007-2008) 52
11.6 Insulin Delivery, India, Company Share (2006-2007) 53
12 Overview of Key Companies in India Diabetes Care Devices Market 54
12.1 Novo Nordisk A/S Company Profile 54
12.1.1 Company Overview 54
12.1.2 Novo Nordisk A/S Pipeline Products 54
12.2 Hindustan Syringes & Medical Devices Ltd. Company Profile 55
12.2.1 Company Overview 55
12.3 F. Hoffmann-La Roche Ltd. Company Profile 56
12.3.1 Company Overview 56
12.3.2 Value Chain Analysis 57
12.3.3 F. Hoffmann-La Roche Ltd Pipeline Products 59
12.4 LifeScan, Inc. Company Profile 60
12.4.1 Company Overview 60
12.4.2 LifeScan, Inc. Pipeline Products 60
12.5 Eli Lilly and Company, Company Profile 62
12.5.1 Company Overview 62
12.5.2 Value Chain Analysis 62
12.5.3 Eli Lilly and Company Pipeline Products 65
12.6 Becton, Dickinson and Company, Company Profile 66
12.6.1 Company Overview 66
12.6.2 Value Chain Analysis 67
12.7 Mehar Healthcare Corporation Company Profile 69
12.7.1 Company Overview 69
13 Financial Deals Landscape 70
13.1 Merger 70
13.1.1 Canere Actives & Fine Chemicals Merges with Nicholas Piramal India 70
13.2 Partnerships 71
13.2.1 Nicholas Piramal India and ARKRAY Forms ARKRAY PIRAMAL Medical 71
14 Recent Developments 72
14.1 Product News 72
14.1.1 Mar 02, 2009: Generex to Present Oral-Lyn at International Conference on Advances in Diabetes and Insulin Therapy 72
15 APPENDIX 73
15.1 Research Methodology 73
15.2 Coverage 74
15.3 Secondary Research 75
15.4 Primary Research 75
15.5 Models 76
15.6 Forecasts 76
15.7 Expert Panel Validation 76
15.8 Currency Conversion 78
15.9 Contact Us 79
15.10 Disclaimer 79

Executive Summary

1.1 List of Tables
Table 1: Number of Doctors by Specialty in India, 2000-2006 16
Table 2: Wards by Specialty in India, 2000-2006 17
Table 3: Diabetes Care Devices, India, Overall Revenue ($ mn), Historic, 2000-2008 24
Table 4: Diabetes Care Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015 25
Table 5: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2008 26
Table 6: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2008-2015 27
Table 7: Diabetes Care Devices, India, Cross Category Analysis, 2000-2015 28
Table 8: Diabetes Burden in India 31
Table 9: Diabetes Care Devices, India Company Share by Revenue ($ mn), 2006-2007 32
Table 10: Glucose Monitoring, India, Revenue ($ mn) by Segment, Historic, 2000-2008 34
Table 11: Glucose Monitoring, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 35
Table 12: Glucose Monitoring, India, Volume (Units) by Segment, Historic, 2000-2008 36
Table 13: Glucose Monitoring, India, Volume (Units) by Segment, Forecast, 2008-2015 37
Table 14: Glucose Monitoring, India, Cross Segment Analysis, 2000-2015 38
Table 15: Glucose Monitoring, India, Average Price ($), Historic, 2000-2008 39
Table 16: Glucose Monitoring, India, Average Price ($), Forecast, 2008-2015 39
Table 17: Glucose Monitoring, India, Distribution Share by Revenue ($mn), 2007-2008 40
Table 18: Glucose Monitoring, India, Company Share by Revenue ($ mn), 2006-2007 41
Table 19: Insulin Delivery, India, Revenue ($ mn) by Segment, Historic, 2000-2008 42
Table 20: Insulin Delivery, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 44
Table 21: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 45
Table 22: Insulin Pens, India, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 46
Table 23: Insulin Delivery, India, Volume (Units) by Segment, Historic, 2000-2008 47
Table 24: Insulin Delivery, India, Volume (Units) by Segment, Forecast, 2008-2015 47
Table 25: Insulin Delivery, India, Cross Segment Analysis, 2000-2015 48
Table 26: Insulin Delivery, India, Average Price ($), Historic, 2000-2008 50
Table 27: Insulin Delivery, India, Average Price ($), Forecast, 2008-2015 50
Table 28: Insulin Delivery, India, Distribution Share by Revenue ($mn), 2007-2008 52
Table 29: Insulin Delivery, India, Company Share by Revenue ($ mn), 2006-2007 53
Table 30: Novo Nordisk A/S Pipeline Products by Equipment Type 54
Table 31: Novo Nordisk A/S Pipeline Products by Development Stage 54
Table 32: Novo Nordisk A/S Pipeline Products by Therapy Area 54
Table 33: Novo Nordisk A/S Pipeline Products by Clinical Trials 54
Table 34: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 59
Table 35: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 59
Table 36: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 59
Table 37: LifeScan, Inc. Pipeline Products by Equipment Type 60
Table 38: LifeScan, Inc. Pipeline Products by Development Stage 60
Table 39: LifeScan, Inc. Pipeline Products by Therapy Area 60
Table 40: LifeScan, Inc. Pipeline Products by Clinical Trials 61
Table 41: LifeScan, Inc. Pipeline Products by News Summary 61
Table 42: Eli Lilly and Company Pipeline Products by Equipment Type 65
Table 43: Eli Lilly and Company Pipeline Products by Development Stage 65
Table 44: Eli Lilly and Company Pipeline Products by Therapy Area 65
Table 45: Eli Lilly and Company Pipeline Products by Clinical Trials 65
Table 46: Eli Lilly and Company Pipeline Products by News Summary 65
Table 47: Canere Actives & Fine Chemicals Merges With Nicholas Piramal India 70
Table 48: Nicholas Piramal India And ARKRAY Forms ARKRAY PIRAMAL Medical 71
Table 49: USD to Local Currency, Average Exchange Rate 2008 78

Novo Nordisk A/S
Hindustan Syringes & Medical Devices Ltd.
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Eli Lilly and Company,
Becton, Dickinson and Company,
Mehar Healthcare Corporation

Customers who bought this item also bought

• Biotechnology in India - Global Business Strategic Report
• Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity
• Biopharmaceutical Manufacturing in India, China and South Korea - Regulatory Framework, Infrastructure Support and Discovery Funding Create an Environment Conducive to Growth
• Biosimilars - Global Strategic Business Report
• Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth
• Indian Industrial Enzymes Market
• Nanobiotechnology Applications, Markets and Companies
• Directory of Top 60 Biopharmaceutical Manufacturers in India
• Biopharmaceuticals - A Global Market Overview
• Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings